Biocon to Partner With CytoSorbents for Sepsis Therapy

Medindia Health News Medindia largest health website in india. // via fulltextrssfeed.com

Learn Adobe Illustrator CS6 Master Techniques from an Adobe Guru! With over 25 years of experience teaching, Robert Farrell has been a trusted instructor for individuals and companies who want to improve their Adobe skills. From our sponsors

Biocon to Partner With CytoSorbents for Sepsis Therapy Sep 14th 2013, 16:29 Biocon Managing Director Kiran Mazumdar Shaw revealed that CytoSorb has been proved to be a 'first-in-class' therapy that is effective in treating sepsis patients. While the financial details of the deal were not revealed, CytoSorbents Chief Executive Officer and President Phillip Chan said that the company will be helped by the strong regional sales and distribution network of Biocon in India. "We are very pleased to enter into this initial agreement with Biocon to bring our potentially life-saving therapy to the people of India and other emerging markets. Unlike any other previous approach, CytoSorbattacks sepsis from multiple angles - reducing cytokine storm, reducing many deadly bacterial toxins, and directing immune cells to target the infection while avoiding damage to otherwise healthy organs.� When combined with Biocon's critical care antibiotics, it is an ideal broad spectrum strategy to fight sepsis", Chan said. Source-Medindia

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions